Virtu KCG Holdings’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Virtu KCG Holdings’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,131	Closed	-$363K	–	4130
2016 Q3	$363K	Buy	+9,131	New	+$102K	0.01%	1717
2015 Q2	–	Sell	-2,544	Closed	-$28K	–	4037
2015 Q1	$28K	Sell	2,544 -596	-19%	-$6.4K	﹤0.01%	2913
2014 Q4	$26K	Buy	+3,140	New	+$27K	﹤0.01%	3570
2014 Q1	–	Sell	-1,525	Closed	-$66K	–	4393
2013 Q4	$66K	Sell	1,525 -1,067	-41%	-$50.1K	﹤0.01%	3546
2013 Q3	$155K	Buy	+2,592	New	+$136K	﹤0.01%	3233

Virtu KCG Holdings's TBRA Position: Q4 2016 in Review

Virtu KCG Holdings sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 9,131 shares — an estimated $363K sold.

Virtu KCG Holdings first reported a position in TBRA in Q3 2013 and held it in 5 quarters. The position peaked at $363K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Virtu KCG Holdings reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Virtu KCG Holdings sold 9,131 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $363K.
Virtu KCG Holdings first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2013 and held it in 5 quarters.
Virtu KCG Holdings's Tobira Therapeutics, Inc. Common Stock position peaked at $363K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.